_________
false
C002
à÷ñ èé àì áéåôøîñåèé÷ìñ áò"î
2
Public
X T L BIOPHARMACEUTICALS LTD
10174
Corporation no:
520039470
Stock Exchange/Market:
NASDAQ CM
1996
380
HaCharoshet st
5
,
Ra'anana
43656
,
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E.mail address:
ir@xtlbio.com
Reported via MAGNA:
22/02/2016
Time of broadcast:
15:42
15:09:12
Company site:
www.xtlbio.com
Reference:
2016-02-032356
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
XTL BIOPHARMACEUTICALS RECEIVES EUROPEAN MEDICINES AGENCY’S SME STATUS
2016_02_22_XTLB_6-K_SME_Status_CLEAN_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
31/01/2016
Name of the Signatory:
:
Kestenbaum David
,
Position of Signatory in the reporting corporation:
Chief Financial Officer
,
Name of Employer Company:
.
Medinat hayehudim st
Telephone:
09-9557080
,
Facsimile:
09-9519727
,
E-mail:
davidk@xtlbio.com
2